Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PROTEOMICS -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (487)	9/30/2003 5:42:20 PM
From: tuck	Read Replies (2) \| Respond to of 539

Looks as though he's looking for licensing deals, huh? Given that the comment Mirkin makes at the end of the article is just a bit promotional: >>"There are established and very good DNA assays, but similar, generally applicable protein assays are not available," says Charles R. Martin, chemistry professor at the University of Florida. "Mirkin takes what works well--DNA assays--and uses them to detect proteins. Very elegant and innovative." Mirkin is more enthusiastic. This method, he claims, could "change diagnostics forever."<< It does seem like something that could be commercialized fairly quickly, so it's worth keeping an eye on. Thanks for that search. Cheers, Tuck